Found: 5
Select item for more details and to access through your institution.
Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls.
- Published in:
- Muscle & Nerve, 2024, v. 70, n. 1, p. 60, doi. 10.1002/mus.28075
- By:
- Publication type:
- Article
Delays in pulmonary decline in eteplirsen-treated patients with Duchenne muscular dystrophy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing.
- Published in:
- International Orthopaedics, 2014, v. 38, n. 5, p. 1025, doi. 10.1007/s00264-014-2293-2
- By:
- Publication type:
- Article
Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 8, p. 3278, doi. 10.1007/s12325-024-02915-9
- By:
- Publication type:
- Article
Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2906, doi. 10.1007/s12325-022-02117-1
- By:
- Publication type:
- Article